story of the week
Toripalimab + Nab-Paclitaxel for Metastatic/Recurrent TNBC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Medicine
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Toripalimab plus nab-paclitaxel in metastatic or recurrent triple-negative breast cancer: a randomized phase 3 trial
Nat. Med. 2024 Jan 08;[EPub Ahead of Print], Z Jiang, Q Ouyang, T Sun, Q Zhang, Y Teng, J Cui, H Wang, Y Yin, X Wang, X Zhou, Y Wang, G Sun, J Wang, L Zhang, J Yang, J Qian, M Yan, X Liu, T Yi, Y Cheng, M Li, A Zang, S Wang, C Wang, X Wu, J Cheng, H Li, Y Lin, C Geng, K Gu, C Xie, H Xiong, X Wu, J Yang, Q Li, Y Chen, F Li, A Zhang, Y Zhang, Y Wu, J Nie, Q Liu, K Wang, X Mo, L Chen, Y Pan, P Fu, H Zhang, D Pang, Y Sheng, Y Han, H Wang, S Cang, X Luo, W Yu, R Deng, C Yang, P KeeganFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.